Fabry Disease
Review articles bring together what experts know so far about one topic. They're a good next step if you want to go deeper than the monthly updates on Fabry disease.
This list only includes reviews published in 2026, newest first. These publications are not summarized or checked here; each link goes to the original, which belongs to its authors and journal. Behind a paywall? Authors are often happy to email a copy if you ask them, and some public libraries can get articles for you. Everything on MedicalUpdates.ai is free.
How to read a review with an AI assistant
For articles marked "Read free full text", you can paste the article into an AI assistant (such as ChatGPT, Claude or Gemini) and ask it to explain it. This prompt asks it to show where each point comes from:
Summarize this review article for a patient with Fabry disease, in plain language. For each main point, quote the sentence from the article it comes from. Keep what the authors found separate from what they suggest or believe. If the article does not say something, write "the article does not say" instead of guessing. End with three questions I could ask my care team.
AI assistants can leave things out or get them wrong, even with this prompt. Check anything important against the article itself. Do not paste your own medical details. This is for understanding, not for making treatment decisions: talk them through with your care team.
Most useful for patients and families (12)
Fabry Disease: Cardiac and Neurologic Involvement.
Monda E, et al. Heart Fail Clin, September 2026
Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine.
Biddeci G, et al. Cells, September 2026
Hereditary cerebral small vessel disease: from phenotype to management.
Gonçalves TAP, et al. Cerebrovasc Dis, September 2026
Clinical manifestations, diagnosis, and management of renal involvement in Fabry disease.
Guo W, et al. Ren Fail, August 2026
Fabry Disease: An Updated Perspective and Review of Treatment and Therapies.
Laney DA, et al. Adv Ther, August 2026
Fabry nephropathy as the clinical anchor for kidney-centered metabolic surveillance: linking genetic heterogeneity to early risk identification.
Xie Y, et al. Front Genet, August 2026
9th Update on Fabry Disease.
Warnock D, et al. Nephron, June 2026
Fabry Disease: Current Perspectives on Diagnosis and Management Strategies.
Norouzi S, et al. Adv Kidney Dis Health, June 2026
Cardiac manifestations of Fabry disease.
Dougherty S, et al. NPJ Cardiovasc Health, March 2026
Advancing Gene Therapies and Novel Treatment Strategies for Infiltrative Cardiomyopathies: A Comprehensive Review of Targeted Interventions.
Shafiei S, et al. Curr Cardiol Rev, March 2026
Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future Directions.
Matucci A, et al. Biomedicines, February 2026
Fabry disease cardiomyopathy: A practical guide for cardiologists.
Al Saleh T, et al. Curr Probl Cardiol, January 2026
More review articles (18)
Many of these go into more clinical or laboratory detail.
Central nervous system biomarkers in Fabry disease: Mechanisms, clinical evidence, and translational integration.
Casazza K, et al. Mol Genet Metab, August 2026
Pain in Fabry disease: do experimental models reveal novel therapeutic targets?
Galimberti G, et al. Biochem Pharmacol, August 2026
Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review.
Aguiar P, et al. Orphanet J Rare Dis, July 2026
Fabry disease cardiomyopathy: Time for a closer heart rhythm monitoring?
Mugnai G, et al. Heart Fail Rev, July 2026
Pathogenic mechanisms in Fabry disease.
Wang S, et al. Front Med (Lausanne), July 2026
Autophagy-Lysosomal Dysfunction as a Converging Mechanism of Cardiomyopathy in Lysosomal Storage Disorders: From Pathobiology to Targeted Therapy.
Lee CL, et al. Int J Mol Sci, July 2026
The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease.
Nekrasova A, et al. Int J Mol Sci, July 2026
Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.
Lattanzio A, et al. Cells, June 2026
Pathophysiological mechanisms of organ injury in Fabry disease: Update via multi-omics.
Wei Z, et al. Genes Dis, May 2026
Artificial Intelligence Application and Future Directions in Infiltrative and Inflammatory Cardiomyopathies: A State-of-the-Art Review.
Tersalvi G, et al. J Card Fail, May 2026
Globotriaosylceramide (Gb3) implications in cardiovascular disease for its mechanistic insights, food chemistry aspects and clinical significance - A review.
Roy V, et al. Int J Biol Macromol, May 2026
Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology.
Elsaid H, et al. Dis Model Mech, May 2026
Arterial spin labeling MRI in CADASIL: Implications for cerebral small vessel disease and therapeutic trials.
Ihara M, et al. Cereb Circ Cogn Behav, April 2026
Interpreting a Thick Myocardium on Cardiac MR: A Practical Guide for Radiologists.
Kim MY, et al. J Korean Soc Radiol, April 2026
Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease.
Simonetta I, et al. Cells, March 2026
Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles.
Giacobbe F, et al. Rev Cardiovasc Med, March 2026
Fabry Disease: A Focus on the Role of Oxidative Stress.
Rydzek J, et al. Antioxidants (Basel), February 2026
Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development.
Gómez-Cebrián N, et al. Front Pharmacol, January 2026
Reviews in other languages (1)
Articles not written in English. PubMed lists an English title, shown here.
Fabry disease beyond the classical model: clinical presentation and diagnostic challenges in women.
Huergo Fernández O, et al. Med Clin (Barc), September 2026